Page last updated: 2024-08-24

cephalosporin c and Acinetobacter Infections

cephalosporin c has been researched along with Acinetobacter Infections in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (4.84)	18.7374
1990's	4 (6.45)	18.2507
2000's	16 (25.81)	29.6817
2010's	34 (54.84)	24.3611
2020's	5 (8.06)	2.80

Authors

Authors	Studies
Heil, EL; Hirsch, EB; Karaba, SM	1
Ju, YG; Lee, HJ; Lee, MG; Sohn, JW; Yim, HS; Yoon, YK	1
Bartolini, A; Bartoloni, A; Bernardo, M; Bianco, V; Botta, A; Faragona, A; Giacometti, A; Giani, T; Graziani, L; Lagi, F; Morroni, G; Parrella, R; Piccica, M; Rossolini, GM; Spinicci, M; Tavio, M	1
Akyüz, S; Güdücüoğlu, H; Parlak, M	1
Kharat, AS; Khobragade, K; Palwe, S; Periasamy, H; Veeraraghavan, B	1
Castanheira, M; Flamm, RK; Jones, RN; Rhomberg, PR; Sader, HS	1
Bangsberg, DR; Bassett, IV; Bazira, J; Bebell, LM; Boatin, AA; Boum, Y; Fajardo, Y; Jacquemyn, Y; Mwanga-Amumpaire, J; Nanjebe, D; Ngonzi, J; Nyehangane, D; Riley, LE; Siedner, MJ; van Geertruyden, JP	1
Echols, R; Hoover, J; Matsumoto, S; Nakamura, R; Rittenhouse, S; Singley, CM; Tsuji, M; Yamano, Y	1
Chmielarczyk, A; Krzyściak, P; Pobiega, M; Romaniszyn, D; Wójkowska-Mach, J	1
Chen, B; Huang, H; Huang, X; Huang, Z; Lian, X; Liu, G; Ran, J; Wang, N	1
Gandra, S; Laxminarayan, R; Logan, LK; Trett, A; Weinstein, RA	1
Agoba, EE; Essack, SY; Govinden, U; Osei Sekyere, J; Peer, AKC	1
Benmahmod, AB; Ibrahim, RH; Said, HS	1
Akova, M; Chen, T; Hua, X; Ji, S; Leptihn, S; Pi, B; Xu, Q; Yan, B; Yang, Y; Yu, Y; Zhang, L; Zhou, Z	1
Biamonte, E; Bruni, A; Garofalo, E; Liberto, MC; Lionello, R; Longhini, F; Marascio, N; Matera, G; Mazzitelli, M; Navalesi, P; Quirino, A; Scaglione, V; Serapide, F; Torti, C; Trecarichi, EM	1
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP	1
Bou, G; Fernández, A; Higgins, PG; Pérez-Llarena, FJ; Seifert, H; Zander, E	1
Chen, JH; He, YQ; Liu, S; Wan, YF; Xu, CQ; Ye, ML; Zheng, YL; Zhou, LY	1
Miller, MJ; Wencewicz, TA	1
Aghazadeh, M; Ghojazadeh, M; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Rezaee, MA	1
Bonnin, RA; Nordmann, P; Poirel, L	1
Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB	1
Antunes, NT; Bhattacharya, M; Smith, CA; Toth, M; Vakulenko, SB	1
Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C	1
Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X	1
Hong, MK; Jeon, JH; Jo, JY; Kang, LW; Karim, AM; Kim, JH; Ko, KS; Lee, JH; Lee, JJ; Lee, SH; Park, KS	1
Alfizah, H; Biglari, S; Rahman, MM; Ramliza, R	1
Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS	1
Dissaneevate, S; Janjindamai, W; Kritsaneepaiboon, S; Maneenil, G; Tanaanantarak, P; Techato, C; Thatrimontrichai, A	1
Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM	1
Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R	1
Diaz-Martinez, LA; Ramirez-Blanco, CE; Ramirez-Rivero, CE; Sosa-Avila, LM	1
Espinal, P; Marti, S; Sánchez-Céspedes, J; Vila, J	1
Lee, HJ; Lee, KM; Suh, JT; Yang, HY	1
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC	1
Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH	1
Bhagan-Bruno, S; Fergus, IV; Lather, N	1
Tuğrul, HM; Yıldırım, MI	1
Amyes, SGB; Lopes, BS	1
Hall, RM; Hamidian, M; Hancock, DP	1
Altouvas, G; Mamali, V; Pitiriga, V; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Tziraki, M; Zarkotou, O	1
Choi, SH; Chung, JW; Hyong Kim, T; Kim, NJ; Kim, YS; Lee, SO; Ryu, J; Woo, JH	1
Gürcan, S; Ozer, B; Shokrylanbaran, N; Tatman-Otkun, M	1
Choi, MK; Fish, DN; Husain, M; Jung, R	1
Astagneau, P; Blanckaert, K; Carbonne, A; Cattoen, C; Chagnon, JL; Couzigou, C; Naas, T; Nordmann, P	1
Koulenti, D; Rello, J	1
Bulitta, J; Kirkpatrick, CM; Lipman, J; Roos, JF	1
Elsa, V; María, A; Nieves, B; Ruíz, J; Ruiz, M; Salazar De Vegas, EZ; Vila, J	1
Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH	1
Chang, KT; Hou, JG; Kwa, AL; Ledesma, KR; Lim, TP; Nikolaou, M; Prince, RA; Quinn, JP; Tam, VH	1
Guérisse, P	1
Butzler, JP; Clumeck, N; George, G; Jaspar, N; Rapin, M; Van Laethem, Y; Vanhoof, R	1
Hedström, SA; Lidgren, L; Nilsson-Ehle, I	1
Kumarasinghe, G; Lee, EJ; Leong, SO; Lye, WC	1
Fraise, AP	1
Akbal, H; Ozturk, R; Saribaş, S; Vahaboglu, H; Yucel, A	1
Arroliga, AC; Fatica, C; Goldstein, LS; Gordon, SM; Hall, GS; Husni, RN; Stoller, JK	1
Iyobe, S; Kobayashi, I; Okubo, T; Takahashi, A; Tsunoda, M; Yomoda, S	1
Bonapace, CR; Bosso, JA; Friedrich, LV; White, RL	1
Gómez Navalón, LA; López Alonso, A; Salido Valle, JA	1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E	1
Hsu, WM; Kao, SC; Kau, HC; Liu, JH; Tsai, CC	1

Reviews

2 review(s) available for cephalosporin c and Acinetobacter Infections

Article	Year
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Transfer, Horizontal; Humans; Minocycline; Mutation; Tigecycline	2013
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12 Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin	2006

Article

Year

Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.

Expert review of anti-infective therapy, 2013, Volume: 11, Issue:6

Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Transfer, Horizontal; Humans; Minocycline; Mutation; Tigecycline

2013

Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.

Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12

Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin

2006

Other Studies

60 other study(ies) available for cephalosporin c and Acinetobacter Infections

Article	Year
In a Pinch: Cefiderocol for CRAB Infections. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Retrospective Studies	2022
In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii. Scientific reports, 2022, 05-09, Volume: 12, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Combinations; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Rifampin; Tazobactam; Tigecycline	2022
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience. The Journal of antimicrobial chemotherapy, 2023, 11-06, Volume: 78, Issue:11 Topics: Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies	2023
[In-vitro Activity of Ceftolozane-Tazobactam in Combination with Various Antibiotics Against Multidrug-resistant Acinetobacter baumannii Isolated from Intensive Care Patients]. Mikrobiyoloji bulteni, 2020, Volume: 54, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Tazobactam	2020
Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; Cephalosporins; China; Drug Combinations; Drug Misuse; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Inappropriate Prescribing; India; Microbial Sensitivity Tests; Patient Care; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam	2020
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases. The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections	2017
Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital. PloS one, 2017, Volume: 12, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Uganda	2017
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Cefiderocol; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections	2017
Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2017, Volume: 125, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aminoglycosides; Anti-Bacterial Agents; Biofilms; Cephalosporins; Cross Infection; Culture Media; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Plankton; Trimethoprim, Sulfamethoxazole Drug Combination	2017
A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii. BMC infectious diseases, 2018, 01-05, Volume: 18, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Cephalosporins; China; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors	2018
Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012. Journal of the Pediatric Infectious Diseases Society, 2019, May-11, Volume: 8, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Logistic Models; Male; Microbial Sensitivity Tests; Prevalence; Regression Analysis; United States	2019
ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Child; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; South Africa	2018
Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World journal of microbiology & biotechnology, 2018, Dec-03, Volume: 34, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; DNA Transposable Elements; Egypt; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing	2018
Dual Role of Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Lepidoptera; Microbial Sensitivity Tests; Minocycline; Tigecycline; Virulence	2019
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. The Journal of antimicrobial chemotherapy, 2019, 11-01, Volume: 74, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Compassionate Use Trials; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Influenza, Human; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Treatment Outcome	2019
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units. Surgical infections, 2013, Volume: 14, Issue:1 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies	2013
OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chromosomes, Bacterial; Cloning, Molecular; DNA Transposable Elements; Escherichia coli; Humans; Isoenzymes; Molecular Sequence Data; Mutation; Plasmids; Recombinant Proteins; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid	2013
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. American journal of infection control, 2013, Volume: 41, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Retrospective Studies; Risk Factors	2013
Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Agar; Anti-Bacterial Agents; Cephalosporins; Culture Media; Ferrous Compounds; Indicators and Reagents; Iron; Microbial Sensitivity Tests; Peptides; Topoisomerase II Inhibitors	2013
Prevalence of Ambler class A β-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Chromosome Mapping; Disk Diffusion Antimicrobial Tests; DNA Mutational Analysis; Humans; Molecular Typing; Mutagenesis, Insertional; Prevalence; Real-Time Polymerase Chain Reaction; Respiratory Tract Infections	2013
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia. Infection control and hospital epidemiology, 2014, Volume: 35, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome	2014
Structure of the extended-spectrum class C β-lactamase ADC-1 from Acinetobacter baumannii. Acta crystallographica. Section D, Biological crystallography, 2014, Volume: 70, Issue:Pt 3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Apoenzymes; Bacterial Proteins; beta-Lactamases; Catalytic Domain; Cephalosporins; Multigene Family; Substrate Specificity	2014
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2014, Volume: 30, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins	2014
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011. The Journal of antibiotics, 2015, Volume: 68, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins	2015
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii. Acta crystallographica. Section D, Biological crystallography, 2014, Volume: 70, Issue:Pt 11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation	2014
Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of Acinetobacter baumannii in a tertiary medical centre in Malaysia. Journal of medical microbiology, 2015, Volume: 64, Issue:Pt 1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Child; Child, Preschool; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Ribosomal; Female; Humans; Infant; Infant, Newborn; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tertiary Care Centers; Young Adult	2015
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins	2016
Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Pneumonia, Ventilator-Associated; Pulmonary Surfactants; Risk Factors; Treatment Outcome	2016
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline	2017
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA	2017
Infection in burn patients in a referral center in Colombia. Burns : journal of the International Society for Burn Injuries, 2017, Volume: 43, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Catheter-Related Infections; Central Venous Catheters; Cephalosporins; Child; Child, Preschool; Colombia; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Folliculitis; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Wound Infection; Young Adult	2017
In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates. International journal of antimicrobial agents, 2009, Volume: 34, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Gene Expression; Genes, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated	2009
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea. Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests	2009
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic	2010
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan	2010
Acinetobacter endocarditis presenting as a large right atrial mass: an atypical presentation. Echocardiography (Mount Kisco, N.Y.), 2010, Volume: 27, Issue:4 Topics: Acinetobacter Infections; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Cefepime; Cephalosporins; Diagnosis, Differential; Endocarditis, Bacterial; Female; Heart Atria; Humans; Kidney Failure, Chronic; Ofloxacin; Ultrasonography; Vancomycin	2010
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3 Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh	2011
Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins. Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA Transposable Elements; DNA, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Order; Humans; Molecular Sequence Data; Promoter Regions, Genetic; Sequence Analysis, DNA	2012
Horizontal transfer of an ISAba125-activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Disease Transmission, Infectious; Humans; Molecular Sequence Data	2013
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens. Journal of clinical microbiology, 2012, Volume: 50, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline	2012
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Logistic Models; Male; Middle Aged; Risk Factors; Thienamycins	2004
Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations. The new microbiologica, 2004, Volume: 27, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Lactams; Microbial Sensitivity Tests	2004
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxifloxacin; Penicillanic Acid; Penicillins; Piperacillin; Quinolines; Tazobactam	2004
Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. The Journal of hospital infection, 2005, Volume: 60, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Utilization; Electrophoresis, Gel, Pulsed-Field; Escherichia coli Proteins; Female; France; Humans; Infection Control; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Phylogeny; Polymerase Chain Reaction; Risk Factors; Time Factors	2005
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections	2006
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela. Medical science monitor : international medical journal of experimental and clinical research, 2007, Volume: 13, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Gentamicins; Humans; Imipenem; Infant, Newborn; Tetracyclines; Venezuela	2007
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter. Scandinavian journal of infectious diseases, 2008, Volume: 40, Issue:3 Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2008
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Antagonism; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2008
Cefuroxime for Acinetobacter infection. Lancet (London, England), 1981, Jul-11, Volume: 2, Issue:8237 Topics: Acinetobacter Infections; Acute Disease; Cefuroxime; Cephalosporins; Humans; Pneumonia	1981
[Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)]. La Nouvelle presse medicale, 1981, Feb-26, Volume: 10, Issue:8 Topics: Acinetobacter Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pneumonia; Urinary Tract Infections	1981
Cefuroxime in acute septic arthritis. Scandinavian journal of infectious diseases, 1984, Volume: 16, Issue:1 Topics: Acinetobacter Infections; Acute Disease; Arthritis, Infectious; Cefuroxime; Cephalosporins; Drug Evaluation; Humans; Kinetics; Staphylococcal Infections; Streptococcal Infections; Synovial Fluid	1984
Clinical characteristics and outcome of Acinetobacter infections in CAPD patients. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1994, Volume: 14, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome	1994
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs). Journal of medical microbiology, 1997, Volume: 46, Issue:6 Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin	1997
Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Pseudomonas aeruginosa; Pseudomonas Infections; Turkey	1998
Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest, 1999, Volume: 115, Issue:5 Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Case-Control Studies; Ceftazidime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Female; Hand Disinfection; Humans; Intensive Care Units; Intubation, Intratracheal; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Risk Factors	1999
Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. Journal of clinical microbiology, 2000, Volume: 38, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins	2000
Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Piperacillin; Reproducibility of Results; Tobramycin	2000
[Alpha-1-antitrypsin in early infections after hip prosthesis surgery]. Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 2000, Volume: 86, Issue:8 Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; alpha 1-Antitrypsin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Sedimentation; C-Reactive Protein; Cefamandole; Cephalosporins; Clinical Enzyme Tests; Data Interpretation, Statistical; Female; Hip Prosthesis; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Postoperative Care; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Tobramycin; Vancomycin	2000
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins	2001
Corneal ulcer of the side port after phacoemulsification induced by Acinetobacter baumannii. Journal of cataract and refractive surgery, 2002, Volume: 28, Issue:5 Topics: Acinetobacter; Acinetobacter Infections; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Ophthalmic Solutions; Phacoemulsification; Surgical Wound Infection	2002